Medicinal Products

Summary

The HSE, responsible for medicine reimbursement decisions under the 2013 Act, will directly provide data on cancer-specific drugs approved from 2019 to 2026.

Marie Sherlock Question Labour Party

372. Deputy Marie Sherlock asked the Minister for Health the number of new cancer specific drugs approved for reimbursement by the HSE for each of the years 2019 to date in 2026. [66166/26]

0 0

Comment on this

Jennifer Carroll MacNeill Minister for Health Fine Gael

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

0 0

Comment on this